SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
BIOTECH: Venter Envisions Shift to Preventive Medicine Through Genomics Research
San Diego super scientist J. Craig Venter has launched a new company, Human Longevity Inc., with an ambitious — albeit ambiguous — pursuit: make people live longer.
BIOTECH: Enzymes Are Targeted to Treat A Variety of Conditions
San Diego-based Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.
PHARMA: Patient Benefits, Patent Lawsuits Are All Part of the Mix
Adamis Pharmaceuticals Corp. stands unique among San Diego’s many drugmakers: It’s going generic.
Tandem Diabetes Care Inc. reported sales of $29 million for the year ended Dec. 31, 2013, compared with $2.5 million for 2012.
Scripps Health broke ground on its new, $175 million medical office building at Scripps Memorial Hospital La Jolla – part of a $2 billion renovation plan for the campus.
Genetic testing company Sequenom Inc. is shaking up its leadership with a number of internal promotions.
Acadia Pharmaceuticals Inc. announced it plans to raise $182 million in a secondary public offering of its common stock, pricing 6.4 million shares at $28.50 apiece.
San Diego-based Tracon Pharmaceuticals Inc. has received $10 million upfront after entering a global development and commercialization deal with Japanese drugmaker Santen Pharmaceutical Co. Ltd.
San Diego super-scientist J. Craig Venter has launched a new company, Human Longevity Inc. that aims to prolong the human lifespan through genomics and cell therapy-based diagnostics.
Connect, a San Diego life sciences and technology nonprofit, has appointed veteran health care and investment banking executive Greg McKee as its new CEO.
Cardium Therapeutics Inc. has entered a strategic collaboration and funding arrangement with Shanxi Taxus Pharmaceuticals Co. Ltd. of China to support the worldwide clinical and commercial development of San Diego-based Cardium’s regenerative medicine therapeutics products.
Acadia Pharmaceuticals Inc. announced it plans to raise $150 million in a secondary public offering of its common stock, though it didn’t indicate how it might use the proceeds.
MEI Pharma Inc.’s investigational drug Pracinostat for treating acute myeloid leukemia has been granted orphan drug designation by the U.S. Food and Drug Administration, the company announced.
Privately held Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.
Isis Pharmaceuticals Inc.’s stock dropped nearly 10 percent following the announcement of its fourth quarter earnings, despite more than doubling its revenue for the quarter ended Dec. 31, 2013. The company’s net loss increased significantly, however.